These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3028132)

  • 1. Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2.
    Kay NE; Zarling J
    Am J Hematol; 1987 Feb; 24(2):161-7. PubMed ID: 3028132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells.
    Kay NE; Zarling JM
    Blood; 1984 Feb; 63(2):305-9. PubMed ID: 6607080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
    Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2.
    Tompkins MB; Pang VF; Michaely PA; Feinmehl RI; Basgall EJ; Baszler TV; Zachary JF; Tompkins WA
    J Immunol; 1989 Jul; 143(2):749-54. PubMed ID: 2544649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL.
    Alvarez de Mon M; Casas J; Laguna R; Toribio ML; de Landázuri MO; Durántez A
    Blood; 1986 Jan; 67(1):228-32. PubMed ID: 3079643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lytic activity of IL-2 and IL-12 stimulated NK cells against HOS osteosarcoma cell line.
    Mariani E; Tarozzi A; Meneghetti A; Tadolini M; Facchini A
    Boll Soc Ital Biol Sper; 1996; 72(1-2):21-7. PubMed ID: 8868111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
    Pattengale PK; Gidlund M; Nilsson K; Sundström C; Sällström J; Simonsson B; Wigzell H
    Int J Cancer; 1982 Jan; 29(1):1-7. PubMed ID: 6174459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro enhancement of natural killer cell activity against herpesvirus-infected targets in patients with acute lymphocytic leukemia.
    McKolanis JR; Ragab AH; Schmid DS
    Arch Virol; 1991; 117(1-2):17-28. PubMed ID: 1848749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME; Thiele DL; Lipsky PE
    J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells.
    Chang WC; Fujimiya Y; Casteel N; Pattengale P
    Int J Cancer; 1989 Apr; 43(4):591-7. PubMed ID: 2522912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia.
    Allen JI; Syropoulos HJ; Grant B; Eagon JC; Kay NE
    J Lab Clin Med; 1987 Apr; 109(4):396-401. PubMed ID: 3493314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.
    Ziegler HW; Kay NE; Zarling JM
    Int J Cancer; 1981 Mar; 27(3):321-7. PubMed ID: 6169660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantation.
    Delmon L; Ythier A; Moingeon P; Nowill A; Bayle C; Pico JL; Hayat M; Ritz J; Hercend T
    Transplantation; 1986 Sep; 42(3):252-6. PubMed ID: 3529526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
    Lotzová E; Savary CA; Herberman RB
    J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
    Abrams SI; Brahmi Z
    Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells.
    Robinson BW; Morstyn G
    Cell Immunol; 1987 May; 106(2):215-22. PubMed ID: 3494538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y; Levanon M; Davidsohn J; Ramot B
    J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.